dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Mateo Valderrama, Joaquim |
dc.contributor.author | Porta, Nuria |
dc.contributor.author | Bianchini, Diletta |
dc.contributor.author | McGovern, Ursula |
dc.contributor.author | Elliott, Tony |
dc.contributor.author | Jones, Robert |
dc.date.accessioned | 2021-08-20T10:01:53Z |
dc.date.available | 2021-08-20T10:01:53Z |
dc.date.issued | 2020-01-01 |
dc.identifier.citation | Mateo J, Porta N, Bianchini D, McGovern U, Elliott T, Jones R, et al. Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol. 2020 Jan;21(1):162-174. |
dc.identifier.issn | 1474-5488 |
dc.identifier.uri | https://hdl.handle.net/11351/6228 |
dc.description | Cáncer de próstata; Olaparib; Aberraciones de genes |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | The Lancet Oncology;21(1) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Medicaments antineoplàstics - Ús terapèutic |
dc.subject | Pròstata - Càncer |
dc.subject | ADN - Reparació |
dc.subject.mesh | Prostatic Neoplasms, Castration-Resistant |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | DNA Repair |
dc.title | Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/S1470-2045(19)30684-9 |
dc.subject.decs | neoplasias prostáticas resistentes a la castración |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | reparación del ADN |
dc.relation.publishversion | https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30684-9/fulltext |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Mateo J] The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Porta N] The Institute of Cancer Research, London, UK. [Bianchini D] The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK. [McGovern U] University College Hospital, University College London Hospitals NHS Foundation Trust, London, UK. [Elliott T] The Christie NHS Foundation Trust, Manchester, UK. [Jones R] University of Glasgow and Beatson West of Scotland Cancer Centre, Glasgow, UK |
dc.identifier.pmid | 31806540 |
dc.identifier.wos | 000505211900062 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |